Viva Biotech
(OTC) VBIZF
Viva Biotech Financials at a Glance
Market Cap
$336.86MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
CN¥3.70B
Net Income (TTM)
CN¥385.43M
EPS (TTM)
$0.01
P/E Ratio
11.14
Dividend
$0.00
Beta (Volatility)
-6.28 (Low)
Dividend
$0.00
Beta (Volatility)
-6.28 (Low)
Price
$0.16
Volume
1,500
Open
$0.16
Price
$0.16
Volume
1,500
Open
$0.16
Previous Close
$0.16
Daily Range
$0.16 - $0.16
52-Week Range
$0.13 - $0.43
Estimated Earnings Date
Aug 31, 2026
Dividend
$0.00
Beta (Volatility)
-6.28 (Low)
Price
$0.16
Volume
1,500
Open
$0.16
Previous Close
$0.16
Daily Range
$0.16 - $0.16
52-Week Range
$0.13 - $0.43
Estimated Earnings Date
Aug 31, 2026
VBIZF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Viva Biotech
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
2,169
CEO
Chen Mao
Website
www.vivabiotech.comHeadquarters
Shanghai, SH 201318, CN
VBIZF Financials
Key Financial Metrics (TTM)
Gross Margin
37.91%
Operating Margin
11.17%
Net Income Margin
12.71%
Return on Equity
5.57%
Return on Capital
3.53%
Return on Assets
3.05%
Earnings Yield
8.98%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$336.86MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
2.09B
Volume
1.50K
Avg. Volume
1.23K
Financials (TTM)
Gross Profit
CN¥1.34B
Operating Income
CN¥421.63M
EBITDA
CN¥825.46M
Operating Cash Flow
CN¥596.02M
Capital Expenditure
-CN¥312.73M
Free Cash Flow
CN¥283.29M
Cash & ST Invst.
CN¥1.13B
Total Debt
CN¥1.33B
Viva Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CN¥882.67M
-12.9%
Gross Profit
CN¥310.88M
-6.5%
Gross Margin
35.22%
N/A
Market Cap
$336.86MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$163.28K
N/A
Employees
2,063
N/A
Net Income
CN¥96.33M
+182.2%
EBITDA
CN¥178.05M
+9.3%
Quarterly Fundamentals
Total Cash
CN¥1.13B
+9.2%
Total Debt
CN¥1.33B
-30.1%
Accounts Receivable
CN¥630.06M
+54.7%
Inventory
CN¥335.91M
+29.3%
Long Term Debt
CN¥358.42M
-62.3%
Short Term Debt
CN¥972.83M
+2.1%
Return on Assets
3.05%
N/A
Return on Invested Capital
3.34%
N/A
Free Cash Flow
CN¥44.98M
+323.6%
Operating Cash Flow
CN¥92.21M
+39.8%